Academia.edu no longer supports Internet Explorer.
To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to upgrade your browser.
2019, J Stem Cell Ther
CD33 also known as Siglec-3 is endogenously expressed in stem cells and is a marker for the myeloid lineage of cells. Increased expression of CD33 thus allows it to bind to any Sialic Acids (SIAs). These acids are binding sites for pathogens and toxins. By binding to these acids, CD33 can prevent invasion of hosts by these pathogens. Down-regulation of CD33, increase the release of the pro-inflammatory cytokine TNF-α by monocytes that increases reactive oxygen species that are involved in diseases like diabetes mellitus, Alzheimer’s, cardiovascular diseases asthma, and in various cancers. The up-regulation of CD33 using Metadichol® was studied using Wharton’s Jelly Mesenchymal Stem Cells (MSCs) isolated from human umbilical cord and were grown in p-35 dishes until confluent and treatment was carried out with different concentrations. One dish was untreated and considered as control. The treated and untreated cells were analyzed using Flow Cytometry. The cells treated at 100 pg of Metadichol® has shown the highest increase (>400 fold) in CD33++ expression (48.77%) compared to untreated control (0.11%).
Journal of Stem Cell Research & Therapy
Metadichol ® a Novel Sialidase Inhibitor2019 •
Humans face a constant threat from pathogens like influenza varieties H1N1, H5N1, and others and there is a need to prevent these from epidemics. The pathogens depend on successful colonization of the host in order to reproduce and multiply. Sialidases are known as neuraminidases are a group of enzymes, the most abundant of these being the exo-sialidases that can catalyze the cleavage of sialic acids from carbohydrates, glycoproteins or glycolipids. Sialidases have been thoroughly studied since their discovery 75 years ago and their occurrence in bacteria and viruses is widespread. They are found in diverse virus families and bacteria and other microbes. Moreover, sialic acids serve as a receptor for various pathogens. This allows bacteria like H1N1 or other influenza viruses, to enter the host cell. There is a need to block sialidases as they release sialic acid that serves as nutrition for the microbes and as well allows them to bind and invade the host cell where they can proliferate. This makes sialidases an interesting target to control pathogenic activity. Metadichol ® is nanoemulsion of long-chain lipid alcohols derived from food ingredients. In rats, it has an LD50 of 5000 mg/kilo and its ingredients are present in many foods we consume on a daily basis. It has antiviral and antibacterial and anti-parasitic properties. We studied inhibition of Sialidases by inducing it with Lipopolysaccharide (LPS) using THP1 cells. Metadichol showed inhibition at 1 picogram per ml to 1 nanogram per/ml. Compared to Prednisone. It is 100 times more active. Previous studies on Metadichol ® showed that it is toxic to cancer cells at higher concentrations. Since it is safer, it has the potential of being directly tested on humans without side effects and could have a potential role in mitigating the pathogens that a burden on the Public health system.
Journal of Stem Cell Research & Therapy
The Quest for Immortality: Introducing Metadichol® a Novel Telomerase Activator2019 •
Humans are keenly aware of their mortality. Given a limited time what we do with our life is a reflection of knowledge of our mortality. In 2009 the Nobel prize in medicine to Jack W Szostak, Elizabeth Blackburn, Carol W Greider for their work on Telomerase and scientific research exploded in this area. Telomere protect chromosome ends the Telomerase enzyme maintains Teleomere length. This activity of Telomerase is essential in aging and stem cells and achieving longer life spans. Telomerase is expressed in 85% of human cancer cell lines, but its enzymatic activity is not detectable in most human somatic cells which constitute the vast majority of the cells in the human body. There is a need for increased telomerase activity in stem cells for use in the treatment of therapies where there is an active role for telomerase. Umbilical Cord Blood (UCB) provides an attractive source of stem cells for research and therapeutic uses. Work shown here characterizes the gene expression changes from Umbilical cord cells differentiate toward telomerase on treatment with Metadichol ®. Metadichol ® is a nanoemulsion of long-chain alcohols that is nontoxic. It is a mixture of long-chain alcohols derived from food. The work presented here is about the effect of Metadichol ® on Telomerase expression profile in Umbilical cord cells. Our results using q-RT-PCR show increases of mRNA telomerase expression by Sixteen-fold at one picogram but down-regulates expression at higher concentrations of 100 pg, 1 ng, 100 ng and one microgram per ml concentration. Western blot studies showed expression of Telomerase protein which is slightly higher than control at one picogram, i.e., Telomerase protein expression continues at replacement level. Since it is devoid of toxic effects, it can be directly tested on humans and is in use today as an immune boosting supplement. Metadichol ® increases expression of Klotho an anti-aging gene expression in cancer cell lines by Four to Tenfold , and Klotho gene has been documented to inhibits the growth of cancer cells. Metadichol ® also inhibits TNF, ICAM1, CCL2, and BCAT1 which that is associated with proliferation in yeast and increased metastatic potential in human cancers. It paves the way for safe clinical testing and research and study of Telomerase biology and its use in humans.
The Indian journal of medical research
Sialic acids siglec interaction: a unique strategy to circumvent innate immune response by pathogens2013 •
Sialic acids (Sias) are nine-carbon keto sugars primarily present on the terminal residue of cell surface glycans. Sialic acid binding immunoglobulins (Ig)-like lectins (siglecs) are generally expressed on various immune cells. They selectively recognize different linkage-specific sialic acids and undertake a variety of cellular functions. Many pathogens either synthesize or acquire sialic acids from the host. Sialylated pathogens generally use siglecs to manipulate the host immune response. The present review mainly deals with the newly developed information regarding mechanism of acquisition of sialic acids by pathogens and their biological relevance especially in the establishment of successful infection by impairing host innate immunity. The pathogens which are unable to synthesize sialic acids might adsorb these from the host as a way to engage the inhibitory siglecs. They promote association with the immune cells through sialic acids-siglec dependent manner. Such an associatio...
Proceedings of the National Academy of Sciences of the United States of America
Specific inactivation of two immunomodulatory SIGLEC genes during human evolution2012 •
Sialic acid-recognizing Ig-like lectins (Siglecs) are signaling receptors that modulate immune responses, and are targeted for interactions by certain pathogens. We describe two primate Siglecs that were rendered nonfunctional by single genetic events during hominin evolution after our common ancestor with the chimpanzee. SIGLEC13 was deleted by an Alu-mediated recombination event, and a single base pair deletion disrupted the ORF of SIGLEC17. Siglec-13 is expressed on chimpanzee monocytes, innate immune cells that react to bacteria. The human SIGLEC17P pseudogene mRNA is still expressed at high levels in human natural killer cells, which bridge innate and adaptive immune responses. As both resulting pseudogenes are homozygous in all human populations, we resurrected the originally encoded proteins and examined their functions. Chimpanzee Siglec-13 and the resurrected human Siglec-17 recruit a signaling adapter and bind sialic acids. Expression of either Siglec in innate immune cell...
Immunological Reviews
The extended human leukocyte receptor complex: diverse ways of modulating immune responses2008 •
Annual Review of Immunology
MACROPHAGE RECEPTORS AND IMMUNE RECOGNITIONPLoS ONE
Engagement of Siglec-7 Receptor Induces a Pro-Inflammatory Response Selectively in Monocytes2012 •
Proceedings of the National Academy of Sciences of the United States of America
Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer2014 •
The Journal of Immunology
FDF03, a Novel Inhibitory Receptor of the Immunoglobulin Superfamily, Is Expressed by Human Dendritic and Myeloid Cells2000 •
Frontiers in immunology
Dendritic cells: a spot on sialic Acid2013 •
European Journal of Immunology
Immune inhibitory receptors: Essential regulators of phagocyte function2011 •
2013 •
Experimental Hematology
Characterization of Siglec-5 (CD170) expression and functional activity of anti–Siglec-5 antibodies on human phagocytes2003 •
Frontiers in immunology
The Inflammatory Role of Platelets via Their TLRs and Siglec Receptors2015 •
International Immunopharmacology
Endogenous lectins shape the function of dendritic cells and tailor adaptive immunity: Mechanisms and biomedical applications2011 •
Molecular and Cellular Biology
CD33/Siglec-3 Binding Specificity, Expression Pattern, and Consequences of Gene Deletion in Mice2003 •
Journal of Clinical Investigation
Induction of myelodysplasia by myeloid-derived suppressor cells2013 •
2012 •
2013 •
Trends in Immunology
Signal regulators in FcR-mediated activation of leukocytes?2004 •
Journal of Allergy and Clinical Immunology
Molecular targets on mast cells and basophils for novel therapies2013 •
Journal of Leukocyte Biology
Sialoglycoproteins adsorbed by Pseudomonas aeruginosa facilitate their survival by impeding neutrophil extracellular trap through siglec-92012 •
Current Stem Cell Reports
The Microbiome and Graft Versus Host Disease2015 •
Journal of Bone and Mineral Research
CD33+ CD14− Phenotype Is Characteristic of Multinuclear Osteoclast-Like Cells in Giant Cell Tumor of Bone2009 •
2011 •
2006 •
Infection and Immunity
Campylobacter jejuni Lipooligosaccharides Modulate Dendritic Cell-Mediated T Cell Polarization in a Sialic Acid Linkage-Dependent Manner2011 •
European Journal of Immunology
Chronic hypoxia reprograms human immature dendritic cells by inducing a proinflammatory phenotype and TREM-1 expression2013 •
BMC Immunology
High glucose concentrations induce TNF-α production through the down-regulation of CD33 in primary human monocytes2012 •
Neurobiology of Aging
Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex2015 •
The Journal of Immunology
CD83 is a sialic acid-binding Ig-like lectin (Siglec) adhesion receptor that binds monocytes and a subset of activated CD8+ T cells2009 •
2014 •
2007 •
Nature Reviews Immunology
A New Self: MHC-Class-I-Independent Natural-Killer-Cell Self-Tolerance2005 •
2009 •
Current Opinion in Immunology
Sialoside-based pattern recognitions discriminating infections from tissue injuries2011 •